CLINICAL_TRIALS
trial_result
· 2016-03-30
Clinical Trial Update: A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia [Phase 3]
Summary
A Phase 3 trial of Mircera for maintenance treatment of anemia in chronic kidney disease has completed. Results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Chronic Renal Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-03-30